Other studies also support the idea that GJIC promotes tumor metastasis (in breast cancer [170] and lymphoma [171], Cx43 and Cx26 in breast cancer and melanoma [172], Cx26 in melanoma [173,174], Cx43 in breast cancer [175], Cx43 in glioma [168,176,177], Cx43 in non-small cell lung cancer [178], and Cx43 in prostate cancer [179], among other studies). Here, GJA1 is linked to breast cancer.